Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Entera Bio Ltda leader in the development of oral peptides and protein replacement therapies announced today that in a written response to a Type A meeting request the US Food and Drug Administration FDA
Bristol Myers Squibb and Bain Capital today announced the creation of a new independent biopharmaceutical company NewCo focused on developing new therapies for autoimmune diseases that address
Biocytogen Pharmaceuticals Beijing Co Ltd Biocytogen HKEX a global biotechnology company that drives the research and development of novel antibodybased drugs with innovative technologies
Alphamab Oncology stock code HK announced that antiHER biparatopic antibodydrug conjugate ADC JSKN has been granted Orphan Drug Designation ODD by the US Food and Drug Administration FDA
Akeso Incis pleased to announce that the National Medical Products Administration NMPA has accepted the supplementary New Drug Application sNDA for ivonescimab PDVEGF bispecific antibody in combination
Shanton Pharma a clinicalstage biotech company developing a novel treatment for gout today announced that FDA has designated its Investigational New Drug SAP as a Fast Track product for treatment
Biostate AI uses RNA sequencing a snapshot of gene activity to build AI models that accurately guide drug development therapy selection and personalized health predictions
Merck a leading science and technology company has signed a nonbinding Memorandum of Understanding MoU with Washington University WashU in St Louis Missouri USA The agreement marks the next chapter
TCG Labs Soleil a venture firm integrating dedicated capital with an inhouse biotech RD hub today announced that it has raised an additional million This new funding builds on the firms inaugural raise of million
Ipsen announced today that the European Commission has approved Cabometyx cabozantinib for adult patients with unresectable or metastatic well differentiated pancreatic pNET and extrapancreatic epNET neuroendocrine tumors who have progressed followin...
